Some patients and advocacy groups see Pharmac as “slow to respond”, “highly defensive” and “lacking respect” for them, according to an independent report released by the drug-funding agency today.
The report – commissioned by Pharmac’s board and based on workshops held late last year – found there was “a credibility and trust gap”.
Pharmac chair Paula Bennett said it was intended to support its “wider reset” to become “more outward focused”.
Discrete choice experiments (DCEs) provide a method for understanding preferences for service provision and there have been limited applications to the selection of community pharmacies. The validity and accuracy of DCEs rely upon the attributes and levels used. This paper aims to describe the development of a DCE investigating New Zealanders preferences for community pharmacies.
Thousands of New Zealanders living with type 1 diabetes face a frustrating wait for potentially life-changing technology, despite a recent announcement from Pharmac that continuous glucose monitors (CGMs) and insulin pumps are now fully funded.
The government is being accused of sacrificing peoples' lives for ideology by delaying bowel cancer screening for Māori and Pacific people from 50 to 58.
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI